Nordwand Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Buy
3,085
+348
+13% +$81.1K 0.12% 106
2026
Q1
$669K Hold
2,737
0.12% 112
2025
Q4
$566K Sell
2,737
-45,209
-94% -$8.94M 0.1% 114
2025
Q3
$8.89M Sell
47,946
-287,900
-86% -$49.3M 1.41% 19
2025
Q2
$51.3M Sell
335,846
-255,838
-43% -$39.3M 8.05% 2
2025
Q1
$98.1M Hold
591,684
36.84% 2
2024
Q4
$85.6M Sell
591,684
-171,378
-22% -$26.6M 35.25% 2
2024
Q3
$124M Buy
763,062
+431,128
+130% +$68.7M 33.1% 2
2024
Q2
$48.5M Hold
331,934
21.16% 2
2024
Q1
$52.5M Sell
331,934
-304,635
-48% -$48.5M 20.4% 2
2023
Q4
$99.8M Sell
636,569
-433,000
-40% -$66.4M 26.33% 2
2023
Q3
$167M Sell
1,069,569
-19
-0% -$3.13K 33% 2
2023
Q2
$177M Buy
1,069,588
+19
+0% +$3.07K 30.34% 2
2023
Q1
$166M Hold
1,069,569
27.01% 2
2022
Q4
$189M Buy
+1,069,569
New +$185M 23.56% 2

Other funds holding JNJ

Nordwand Advisors's JNJ Position: Q2 2026 in Review

Nordwand Advisors increased its Johnson & Johnson (JNJ) stake by 13% in Q2 2026, buying an estimated $81.1K and bringing the position to 3,085 shares worth $783K. The position accounts for 0.12% of the portfolio, ranked #106.

Nordwand Advisors first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $189M in Q4 2022. 4,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nordwand Advisors held 3,085 shares of Johnson & Johnson worth $783K as of Q2 2026.
  • Nordwand Advisors bought 348 Johnson & Johnson shares in Q2 2026, an estimated $81.1K.
  • Johnson & Johnson made up 0.12% of Nordwand Advisors's portfolio in Q2 2026, its #106 holding.
  • Nordwand Advisors first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Nordwand Advisors's Johnson & Johnson position peaked at $189M in Q4 2022.
  • 4,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nordwand Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.